SCHEMBL31428847

SCHEMBL31428847

CC(=O)N1/C(=C\c2ccc3c(-c4cccc5ccccc45)c(C(=O)N4CCOCC4)ccc3n2)C(=O)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAUR Q03405 3/20 0.42
TP53 P04637 2/20 0.42
HTR2C P28335 5/20 0.41
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 2/20 0.39
USP2 O75604 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FNTA P49354 3/20 0.39
FNTB P49356 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MOK Q9UQ07 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428717 0.88 TP53 (0.40) PLAURTP53ALDH1A1TSHRLMNA
SCHEMBL31428704 0.85 ALDH1A1 (0.52) PLAURTP53ALDH1A1TSHRLMNA
SCHEMBL31428973 0.84 PDCD1 (0.44) PLAURTP53HTR2CALDH1A1TSHR
SCHEMBL31428781 0.84 PLAUR (0.38) PLAURTP53ALDH1A1TSHRLMNA
SCHEMBL31429073 0.84 PLAUR (0.38) PLAURTP53ALDH1A1TSHRLMNA
SCHEMBL24977244 0.81 HTR2C (0.50) PLAURTP53HTR2CALDH1A1TSHR
SCHEMBL31428698 0.81 HTR2C (0.50) PLAURTP53HTR2CALDH1A1TSHR
SCHEMBL31428738 0.80 HTR2C (0.40) PLAURHTR2CALDH1A1KDM4EHPGD
SCHEMBL31428538 0.80 HPGD (0.46) PLAURALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL31429062 0.79 ALDH1A1 (0.41) PLAURTP53ALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS PLAUR 3817/4885TP53 34/4885HTR2C 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.